EX-32.1 8 ex_110393.htm EXHIBIT 32.1 ex_110393.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

 

In connection with the Annual Report of CEN Biotech, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, Joseph Byrne, Chief Executive Officer, do hereby certify, to my knowledge:

 

(1) The Annual Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: April 16, 2018

 

 

 

 

By:

/s/ Joseph Byrne

 

 

Joseph Byrne

 

 

Chief Executive Officer

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CEN Biotech, Inc. and will be retained by CEN Biotech, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.